Treat this cluster as routine portfolio diversification or tax-driven selling. The dollar amount is noise at DGX's scale, and insider sells lack predictive power for large-cap healthcare services. Monitor next quarter's 10-Q or 8-K for any revenue/earnings pressure only if a coincident business filing appears.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 4 $236.26entry
- T+1 · 2mo ago −0.69%α −0.14% · $234.63
- T+5 · 2mo ago +0.32%α +1.53% · $237.01
- T+20 · 6w ago −2.07%α −2.93% · $231.36
- T+50 · todayOpen
- T+60 · in 14d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Two senior insiders at Quest Diagnostics sold a combined $6.32M in open-market transactions over a 7-day window, including the CEO/President and the SVP & General Counsel. The CEO's sale alone was $2.43M at ~$242.72, and the General Counsel sold $3.89M at ~$242.88. At a $26.6B market cap, the cluster represents ~0.024% of market cap, well below the 0.1% materiality threshold, and lacks a certifiable bearish catalyst, making this a routine liquidity/planning event rather than a directional signal.
Key Financial Metrics
Key Facts
- CEO Davis J.E. sold 10,000 shares at $242.72, totaling $2.43M on 2026-09-01.
- SVP & General Counsel Prevoznik sold 16,000 shares at $242.88, totaling $3.89M on 2026-08-28.
- Total cluster value of $6.32M represents ~0.024% of DGX's $26.6B market cap.
- Net direction: 100% selling; no open-market buys in the cluster.
- Both sales occurred in the same week, consistent with a blackout-window opening or shared 10b5-1 plan timing.
- No earnings, guidance, or corporate action was filed in the same period to suggest non-public negative information.
Financial Impact
Total insider sales of $6.32M, trivial relative to $26.6B market cap (~0.024%); non-sentiment-significant per academic literature on cluster sells.
Risk Factors
- CEO and General Counsel selling concurrently could indicate shared bearish view despite low proportionality, but academic evidence shows cluster sells are no more informative than non-cluster sells.
- If an undisclosed earnings warning or restructuring filing surfaces within the next 30 days, these sales would gain ex post significance.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DGX-1788505349930 |
Track record
24 reports on DGX
3 of 3 bullish or bearish reports moved the stock their way by T+60. Best: +7.06% at T+5 after the Sep 9, 2026 report. 5 of 5 went positive at some point.
Filters
- Nov 16, 2026today Insider Cluster Neutral 2/10 Entry price pending
- Nov 12, 20264d ago Insider Cluster Neutral 2/10 Entry $259.60 Now $262.21 +1.01% settles Feb 11
- Nov 10, 20266d ago Press Release Neutral 2/10 Entry $258.69 Now $262.21 +1.36% settles Feb 9
- Nov 10, 20266d ago SC 13G Neutral 3/10 Entry $258.44 Now $262.21 +1.46% settles Feb 8
- Nov 9, 20267d ago Press Release Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 9, 20267d ago 144 Neutral 2/10 Entry $259.67 Now $262.21 +0.98% settles Feb 5
- Nov 5, 202611d ago 3 Neutral 2/10 Entry $255.63 Now $262.21 +2.57% settles Feb 4
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Nov 3, 202613d ago 144 Neutral 3/10 Entry $247.06 Now $262.21 +6.13% settles Feb 1
- Oct 27, 202620d ago Institutional Cluster Mixed 3/10 Entry $245.62 Now $262.21 +6.75% settles Jan 26
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers